Skip to main content
Clinical Trials/IRCT20180818040827N2
IRCT20180818040827N2
Recruiting
未知

Evaluation of the effect of synbiotic supplementation on antioxidant and inflammatory markers, serum zonulin level and quality of life in patients with Parkinson's disease

Esfahan University of Medical Sciences0 sites80 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
80
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who agree to participate in the study
  • Diagnosis of Parkinson's by a neurologist based on the diagnostic criteria of the Parkinson's Disease Association (UK Parkinson's disease society Brain Bank criteria)
  • Age 50 to 80 years

Exclusion Criteria

  • Regular consumption of products fortified with probiotics and prebiotics, probiotic and prebiotics supplements at least 2 months before start of the study
  • Take antibiotics or laxatives at least 2 months before the start of the study
  • Take antioxidant supplements or supplements that affect the disease
  • Having a history of gastrointestinal surgery
  • History of chronic gastrointestinal disease, hypothyroidism or hyperthyroidism, severe psychosis, or other concomitant neurological diseases, cognitive impairment, smoking or nicotine or alcohol use
  • Having a history of type 1 and 2 diabetes
  • Taking anti\-inflammatory and immunosuppressive drugs
  • Sensitivity to the compounds in the supplement
  • Having hoehn and yahr score of 5 out of 5

Outcomes

Primary Outcomes

Not specified

Similar Trials